Mei Wu Hua Announces Newly Elected Board of Directors (Regular Election upon Term Expiration)

1. Date of Change: 115/06/10 2. Category of Appointed or Changed Personnel (please specify: corporate director, corporate supervisor, independent director, individual director, or individual supervisor): Corporate Director, Independent Director. 3. Previous Position and Name: (1) Director: Li Cheng-Jia, legal representative of Cheng-Yi Investment Co., Ltd. (2) Director: Li Yi-Li, legal representative of Cheng-Yi Investment Co., Ltd. (3) Director: Li Yi-Ling, legal representative of Li-Ling Investment Co., Ltd. (4) Director: Lai Yu-Ju, legal representative of Cheng-Yi Investment Co., Ltd. (5) Director: Chen Wen-Hua, legal representative of Hua-Wei Co., Ltd. (6) Director: Liu Wen-Zheng, legal representative of Hua-Wei Co., Ltd. (7) Director: Li Bi-Zhen, legal representative of Li-Ling Investment Co., Ltd. (8) Director: Li Yu-Jia, legal representative of Yi-Xin International Co., Ltd. (9) Director: Yu Chang-Min, legal representative of Yi-Xin International Co., Ltd. (10) Independent Director: Chen Hui-You (11) Independent Director: Ou Shu-Fang (12) Independent Director: Zhang Hong-Ren (13) Independent Director: Lin Qi-Feng 4. Previous Personnel Resume: (1) Director: Li Cheng-Jia, legal representative of Cheng-Yi Investment Co., Ltd., Chairman of the Company. (2) Director: Li Yi-Li, legal representative of Cheng-Yi Investment Co., Ltd., Vice Chairman of the Company, Chairman of White Biotech New Drug and Anker Medical Devices Co., Ltd. (3) Director: Li Yi-Ling, legal representative of Li-Ling Investment Co., Ltd., Executive Director of the Company, Vice Chairman of White Biotech New Drug and Anker Medical Devices Co., Ltd. (4) Director: Lai Yu-Ju, legal representative of Cheng-Yi Investment Co., Ltd., Director and General Manager of the Company. (5) Director: Chen Wen-Hua, legal representative of Hua-Wei Co., Ltd., Director of the Company. (6) Director: Liu Wen-Zheng, legal representative of Hua-Wei Co., Ltd., Director of the Company. (7) Director: Li Bi-Zhen, legal representative of Li-Ling Investment Co., Ltd., Director of the Company. (8) Director: Li Yu-Jia, legal representative of Yi-Xin International Co., Ltd., Director of the Company. (9) Director: Yu Chang-Min, legal representative of Yi-Xin International Co., Ltd., Director and Deputy General Manager of Mei Wu Fa Division. (10) Independent Director: Chen Hui-You, Independent Director of the Company. (11) Independent Director: Ou Shu-Fang, Independent Director of the Company. (12) Independent Director: Zhang Hong-Ren, Independent Director of the Company. (13) Independent Director: Lin Qi-Feng, Independent Director of the Company. 5. New Position and Name: (1) Director: Li Cheng-Jia, legal representative of Cheng-Yi Investment Co., Ltd. (2) Director: Li Yi-Li, legal representative of Cheng-Yi Investment Co., Ltd. (3) Director: Li Yi-Ling, legal representative of Li-Ling Investment Co., Ltd. (4) Director: Lai Yu-Ju, legal representative of Cheng-Yi Investment Co., Ltd. (5) Director: Li Yu-Jia, legal representative of Cheng-Yi Investment Co., Ltd. (6) Director: Li Bi-Zhen, legal representative of Li-Ling Investment Co., Ltd. (7) Director: Yu Chang-Min, legal representative of Li-Ling Investment Co., Ltd. (8) Director: Liu Wen-Zheng, legal representative of Hua-Wei Co., Ltd. (9) Director: Lai Shu-Tzu, legal representative of Hua-Wei Co., Ltd. (10) Independent Director: Chen Hui-You (11) Independent Director: Ou Shu-Fang (12) Independent Director: Zhang Hong-Ren (13) Independent Director: Lin Qi-Feng 6. New Personnel Resume: (1) Director: Li Cheng-Jia, legal representative of Cheng-Yi Investment Co., Ltd., Chairman of the Company. (2) Director: Li Yi-Li, legal representative of Cheng-Yi Investment Co., Ltd., Vice Chairman of the Company, Chairman of White Biotech New Drug and Anker Medical Devices Co., Ltd. (3) Director: Li Yi-Ling, legal representative of Li-Ling Investment Co., Ltd., Executive Director of the Company, Vice Chairman of White Biotech New Drug and Anker Medical Devices Co., Ltd. (4) Director: Lai Yu-Ju, legal representative of Cheng-Yi Investment Co., Ltd., Director and General Manager of the Company. (5) Director: Li Yu-Jia, legal representative of Cheng-Yi Investment Co., Ltd., Director of the Company. (6) Director: Li Bi-Zhen, legal representative of Li-Ling Investment Co., Ltd., Director of the Company. (7) Director: Yu Chang-Min, legal representative of Li-Ling Investment Co., Ltd., Director and Deputy General Manager of Mei Wu Fa Division. (8) Director: Liu Wen-Zheng, legal representative of Hua-Wei Co., Ltd., Director of the Company. (9) Director: Lai Shu-Tzu, legal representative of Hua-Wei Co., Ltd., Independent Director of Deng-Feng Microelectronics Co., Ltd. (10) Independent Director: Chen Hui-You, Independent Director of the Company. (11) Independent Director: Ou Shu-Fang, Independent Director of the Company. (12) Independent Director: Zhang Hong-Ren, Independent Director of the Company. (13) Independent Director: Lin Qi-Feng, Independent Director of the Company. 7. Change Status (please enter 'resignation', 'dismissal', 'end of term', 'deceased', or 'new appointment'): End of Term 8. Reason for Change: Full re-election upon expiration of term 9. Shareholding of New Appointees at Time of Election: (1) Director: Li Cheng-Jia, legal representative of Cheng-Yi Investment Co., Ltd.: 23,594,819 shares. (2) Director: Li Yi-Li, legal representative of Cheng-Yi Investment Co., Ltd.: 23,594,819 shares. (3) Director: Li Yi-Ling, legal representative of Li-Ling Investment Co., Ltd.: 14,946,556 shares. (4) Director: Lai Yu-Ju, legal representative of Cheng-Yi Investment Co., Ltd.: 23,594,819 shares. (5) Director: Li Yu-Jia, legal representative of Cheng-Yi Investment Co., Ltd.: 23,594,819 shares. (6) Director: Li Bi-Zhen, legal representative of Li-Ling Investment Co., Ltd.: 14,946,556 shares. (7) Director: Yu Chang-Min, legal representative of Li-Ling Investment Co., Ltd.: 14,946,556 shares. (8) Director: Liu Wen-Zheng, legal representative of Hua-Wei Co., Ltd.: 78,000 shares. (9) Director: Lai Shu-Tzu, legal representative of Hua-Wei Co., Ltd.: 78,000 shares. (10) Independent Director Chen Hui-You: 0 shares. (11) Independent Director Ou Shu-Fang: 0 shares. (12) Independent Director Zhang Hong-Ren: 0 shares. (13) Independent Director Lin Qi-Feng: 0 shares. 10. Previous Term (e.g., xx/xx/xx ~ xx/xx/xx): 112/05/26 ~ 115/05/25 11. Effective Date of New Appointment: 115/06/10 12. Director Turnover Rate During Same Term: Not applicable 13. Independent Director Turnover Rate During Same Term: Not applicable 14. Supervisor Turnover Rate During Same Term: Not applicable 15. More than one-third of directors changed (enter yes or no): No 16. Other Matters to be Clarified (if the subject is a publicly issued company or above, this major information simultaneously meets Article 7, Paragraph 6 of the Enforcement Rules of the Securities and Exchange Act regarding matters having significant impact on shareholders' rights or securities prices): None